Atlas Trials

Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia

Clinical trial NCT05838625 · COMPLETED

Trial details

NCT number
NCT05838625
Sponsor
Click Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2023-03-31
Primary completion
2025-06-20
Enrollment
464

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.